118 related articles for article (PubMed ID: 38277750)
1. Exploring the therapeutic potential of curcumin in oral squamous cell carcinoma (HSC-3 cells): Molecular insights into hypoxia-mediated angiogenesis.
Jayaraman S; Veeraraghavan VP; Natarajan SR; Jasmine S
Pathol Res Pract; 2024 Feb; 254():155130. PubMed ID: 38277750
[TBL] [Abstract][Full Text] [Related]
2. Overcoming chemotherapy resistance using pH-sensitive hollow MnO
Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP
J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370
[TBL] [Abstract][Full Text] [Related]
3. Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1.
Bae MK; Kim SH; Jeong JW; Lee YM; Kim HS; Kim SR; Yun I; Bae SK; Kim KW
Oncol Rep; 2006 Jun; 15(6):1557-62. PubMed ID: 16685395
[TBL] [Abstract][Full Text] [Related]
4. Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF.
Shao S; Duan W; Xu Q; Li X; Han L; Li W; Zhang D; Wang Z; Lei J
Oxid Med Cell Longev; 2019; 2019():8148510. PubMed ID: 30800209
[TBL] [Abstract][Full Text] [Related]
5. Curcumin analog, GO-Y078, induces HO-1 transactivation-mediated apoptotic cell death of oral cancer cells by triggering MAPK pathways and AP-1 DNA-binding activity.
Chien MH; Shih PC; Ding YF; Chen LH; Hsieh FK; Tsai MY; Li PY; Lin CW; Yang SF
Expert Opin Ther Targets; 2022 Apr; 26(4):375-388. PubMed ID: 35361044
[TBL] [Abstract][Full Text] [Related]
6. RNA interference-mediated downregulation of hypoxia-inducible factor-1α inhibits angiogenesis and survival of oral squamous cell carcinoma in vitro and in vivo.
Zhou H; Fei W; Bai Y; Zhu S; Luo E; Chen K; Hu J
Eur J Cancer Prev; 2012 May; 21(3):289-99. PubMed ID: 22113109
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma.
Wang WM; Zhao ZL; Ma SR; Yu GT; Liu B; Zhang L; Zhang WF; Kulkarni AB; Sun ZJ; Zhao YF
PLoS One; 2015; 10(2):e0119723. PubMed ID: 25723392
[TBL] [Abstract][Full Text] [Related]
8. Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in
Alam MM; Fermin JM; Knackstedt M; Noonan MJ; Powell T; Goodreau L; Daniel EK; Rong X; Moore-Medlin T; Khandelwal AR; Nathan CO
Oncotarget; 2023 Feb; 14():85-95. PubMed ID: 36745547
[No Abstract] [Full Text] [Related]
9. MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression.
Kim S; Park S; Oh JH; Lee SS; Lee Y; Choi J
BMC Oral Health; 2022 Sep; 22(1):378. PubMed ID: 36064348
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers of angiogenesis and metastasis in lines of oral carcinoma after treatment with melatonin.
Goncalves Ndo N; Rodrigues RV; Jardim-Perassi BV; Moschetta MG; Lopes JR; Colombo J; Zuccari DA
Anticancer Agents Med Chem; 2014; 14(9):1302-11. PubMed ID: 25323035
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer.
Han JY; Oh SH; Morgillo F; Myers JN; Kim E; Hong WK; Lee HY
J Natl Cancer Inst; 2005 Sep; 97(17):1272-86. PubMed ID: 16145048
[TBL] [Abstract][Full Text] [Related]
12. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced up-regulation of angiogenin, besides VEGF, is related to progression of oral cancer.
Kishimoto K; Yoshida S; Ibaragi S; Yoshioka N; Okui T; Hu GF; Sasaki A
Oral Oncol; 2012 Nov; 48(11):1120-7. PubMed ID: 22694909
[TBL] [Abstract][Full Text] [Related]
14. PARP inhibitor Veliparib (ABT-888) enhances the anti-angiogenic potentiality of Curcumin through deregulation of NECTIN-4 in oral cancer: Role of nitric oxide (NO).
Chatterjee S; Sinha S; Molla S; Hembram KC; Kundu CN
Cell Signal; 2021 Apr; 80():109902. PubMed ID: 33373686
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia inducible factor-1α expression in areca quid chewing-associated oral squamous cell carcinomas.
Lee SS; Tsai CH; Yang SF; Ho YC; Chang YC
Oral Dis; 2010 Oct; 16(7):696-701. PubMed ID: 20846156
[TBL] [Abstract][Full Text] [Related]
18. Correlation between VEGF and HIF-1alpha expression in human oral squamous cell carcinoma.
Mohamed KM; Le A; Duong H; Wu Y; Zhang Q; Messadi DV
Exp Mol Pathol; 2004 Apr; 76(2):143-52. PubMed ID: 15010293
[TBL] [Abstract][Full Text] [Related]
19. Modulation of growth and angiogenic potential of oral squamous carcinoma cells in vitro using salvianolic acid B.
Yang Y; Ge PJ; Jiang L; Li FL; Zhu QY
BMC Complement Altern Med; 2011 Jul; 11():54. PubMed ID: 21726465
[TBL] [Abstract][Full Text] [Related]
20. Novel HDGF/HIF-1α/VEGF axis in oral cancer impacts disease prognosis.
Lin YW; Huang ST; Wu JC; Chu TH; Huang SC; Lee CC; Tai MH
BMC Cancer; 2019 Nov; 19(1):1083. PubMed ID: 31711427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]